Lynx Capital Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Lynx Capital Group's MRK Position: Q3 2026 in Review
Lynx Capital Group reduced its Merck (MRK) stake by 0.78% in Q3 2026, selling an estimated $30K and leaving 27,662 shares worth $4.02M. The position accounts for 1.58% of the portfolio, ranked #23.
Lynx Capital Group first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Lynx Capital Group held 27,662 shares of Merck worth $4.02M as of Q3 2026.
- Lynx Capital Group sold 217 Merck shares in Q3 2026, an estimated $30K.
- Merck made up 1.58% of Lynx Capital Group's portfolio in Q3 2026, its #23 holding.
- Lynx Capital Group first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Lynx Capital Group's 13F filing for Q3 2026, filed 4 Nov 2026.